Zai Lab Limited - American Depositary Shares — Quarterly Financial Statistics (NASDAQ:ZLAB) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 26.82 M55.77 M61.7 M31.02 M32.04 M26.02 M 150.79 M Cash from investing activities 24.99 M347.75 M326.13 M-2.92 M-4.05 M-11.3 M 307.87 M Cash from financing activities 42.21 M237.81 M43.14 M8.85 M20.79 M-430 K 72.35 M Free cash flow -3.06 M38.02 M57.83 M26.85 M27.96 M24.72 M 137.37 M

ニュース

Zai Lab Q4 2025 slides: Zoci pipeline drives dual-engine strategy

Zai Lab earnings beat by $0.32, revenue topped estimates

Baron Emerging Markets Fund Q4 2025 Portfolio Activity

Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.

今四半期で最大の利益をもたらす可能性があるトップ3の医療株

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

ザイラボ株、52週間安値の16.78ドルを記録

Zai Lab stock hits 52-week low at 16.78 USD

Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:ZLAB) 2026-01-15

UBSがZai Lab株を「買い」評価で開始、目標価格35ドル

UBS initiates Zai Lab stock with Buy rating, $35 price target